Truepoint, Inc. Abbott Laboratories Transaction History
Truepoint, Inc.
- $3.66 Billion
- Q4 2024
A detailed history of Truepoint, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Truepoint, Inc. holds 2,339 shares of ABT stock, worth $298,035. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,339
Previous 2,169
7.84%
Holding current value
$298,035
Previous $247,000
6.88%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ABT
# of Institutions
3,378Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$21.5 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$9.83 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.66 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$6.89 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $223B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...